We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Award of share options/director dealing

29 Jun 2018 07:11

RNS Number : 0222T
LiDCO Group Plc
29 June 2018
 

29 June 2018

LiDCO Group Plc

("LiDCO" or the "Company")

 

Award of share options/director dealing

 

LiDCO (AIM: LID), the hemodynamic monitoring company, announces that following the notification in the Annual Report, on 20 April 2018, the Board finalised a grant of options ("Options") to Mr Sassone, CEO, to subscribe for new ordinary shares of 0.5p each ("Ordinary Shares"). 

 

Option type

Number of shares over which options granted

Total number of options held post grant

Percentage of issued share capital under option

Matt Sassone

Unapproved

1,000,000

4,147,342

1.70%

EMI

3,448,262

1.41%

Total

1,000,000

7,595,604

3.11%

 

The above Options vest and may be exercised three years from grant if certain share price hurdles are met. The Options are exercisable over a range of periods at 0.5 pence per Ordinary Share, subject to the Company's share price averaging above a number of hurdle rates. The expiry date is April 2023. The hurdle rates were set with regard to the closing midmarket price on Thursday 19 April and are between 8.38p and 12.38p.

 

Full details of these Options and others held are given in the Company's report and accounts (Directors' remuneration report) which are available on the Company's website.

 

The below notification is made in accordance with the requirements of the EU Market Abuse Regulation.

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Matt Sassone

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

LiDCO Group Plc

b)

LEI:

213800PYQTIUV6HIYL36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 0.5p nominal

 

GB0030546849

b)

Nature of the transaction:

Grant of Management Share Options

c)

Price(s) and volume(s):

 

Price(s)

Volume(s)

0.5p

1,000,000

d)

Aggregated information:

· Aggregated volume:

· Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

0.5p

7,595,604

e)

Date of the transaction:

20/04/18

f)

Place of the transaction:

London Stock Exchange, AIM (XLON)

 

 

For further information, please contact:

 

LiDCO Group Plc

www.lidco.com

Matt Sassone (CEO)

Tel: +44 (0)20 7749 1500

 

 

finnCap

Tel: +44 (0)20 7600 1658

Geoff Nash / Emily Watts (Corporate Finance)

Stephen Norcross (Corporate Broking)

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 or lidco@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Lianne Cawthorne

Mob: 07584 391 303

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHLIFLRRIIAFIT
Date   Source Headline
14th Feb 20181:15 pmRNSHolding(s) in Company
1st Feb 20187:00 amRNSBlock Listing Review
17th Jan 20187:00 amRNSJapan registration &appointment of new distributor
15th Jan 201810:06 amRNSHolding(s) in Company
13th Dec 20174:33 pmRNSHolding(s) in Company
22nd Nov 20179:28 amRNSHolding(s) in Company
10th Oct 20177:00 amRNSHalf-year Report
10th Aug 20177:01 amRNSTrading update & Notice of results
10th Aug 20177:00 amRNSFirst High Usage Programme Account in US
1st Aug 20177:00 amRNSBlock Listing Review
25th Jul 20174:37 pmRNSHolding(s) in Company
6th Jul 20177:00 amRNSConfirmation of CFO appointment & Award of options
8th Jun 20177:00 amRNSInvestor presentation
7th Jun 20177:00 amRNSUS FDA clearance for LiDCOunity v2
10th May 201711:35 amRNSResult of AGM
10th May 20177:00 amRNSAGM Statement
9th May 20177:00 amRNSNew LiDCOunity v2 monitor launch
4th May 20177:00 amRNSLaunch of new website
28th Apr 20177:00 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSAward of share options/ director dealing
3rd Apr 20177:00 amRNSInvestor presentation
3rd Apr 20177:00 amRNSDirector/PDMR Shareholding
28th Mar 20177:00 amRNSFinal Results
13th Mar 20177:00 amRNSNotice of Results
1st Mar 20177:00 amRNSBoard Changes
16th Feb 201710:07 amRNSHolding(s) in Company
14th Feb 20177:00 amRNSTrading update and notice of results
3rd Feb 20177:00 amRNSHolding(s) in Company
19th Jan 201710:29 amRNSHoldings in Company
18th Jan 20177:00 amRNSHolding(s) in Company
10th Jan 20177:00 amRNSAppointment of Head of North America
3rd Jan 20171:03 pmRNSHolding(s) in Company
3rd Jan 201712:31 pmRNSHolding(s) in Company
3rd Jan 201712:30 pmRNSHolding(s) in Company
23rd Dec 201610:23 amRNSResult of GM, TVR and Transactions by PDMRs
7th Dec 20167:00 amRNSProposed Placing & Notice of General Meeting
11th Oct 20167:00 amRNSHalf-year Report
20th Sep 20167:00 amRNSNotice of Results
8th Sep 20167:00 amRNSFurther clinical support for LiDCOrapid
7th Sep 20163:46 pmRNSHolding(s) in Company
11th Aug 20167:01 amRNSAppointment of Non Executive Director
11th Aug 20167:00 amRNSTrading update and notice of results
1st Jun 20169:17 amRNSHolding(s) in Company
25th May 201612:28 pmRNSResult of AGM
25th May 20167:00 amRNSAGM Statement
16th May 20167:00 amRNSUS Distribution Agreement with ICU Medical
6th May 20167:00 amRNSNotice of AGM
21st Apr 20167:00 amRNSUS launch of new LiDCOunity monitor
4th Apr 20167:00 amRNSUS FDA 510k clearance for LiDCOunity
30th Mar 201611:23 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.